Aptar Pharma and MGH Collaborate to Advance Nose-to-Brain Drug Delivery
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, recently announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH) to advance the science of nose-to-brain (N2B) drug delivery. Aptar and its collaborators will develop an […]
GENESIS Pharma Broadens Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics Across Nordic Markets
GENESIS Pharma, one of the leading regional biopharma companies focused on the commercialisation of innovative medicines in Europe, on June 10th, announced the expansion of its longstanding commercial partnership with Alnylam Pharmaceuticals, Inc., one of the leading RNAi therapeutics companies. The extended agreement broadens the geographical reach of the collaboration to include four Nordic markets […]
Stevanato Group Launches Deora Pen Injector for Diabetes and Weight Management Therapies
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries, recently introduced Deora, a new proprietary pen injector platform targeting incretin-based therapies, as well as supporting other originator and biosimilar drug development programs. Deora is a multi-use, fixed-dose pen injector featuring […]
ATB Therapeutics Names Mark Throsby CEO to Drive Next Growth Phase
ATB Therapeutics, a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, on May 19th announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. Mark Throsby has served as Executive Chairman and Chief […]
TetraScience Announces Partnership with NVIDIA for Industrial Enterprises of Scientific AI
TetraScience recently announced it is collaborating with NVIDIA to accelerate innovation in the USD 1.5 trillion life sciences industry by bringing standardization and scalability to the development and implementation of scientific AI. The biopharma industry is racing to unlock AI’s potential across thousands of scientific use cases. However, millions of silos of proprietary and unstructured data […]
Veracyte Announces Appointment of Brent Shafer and Tom Miller, Ph.D., to Its Board
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, recently announced the appointment of Brent Shafer and Tom Miller, Ph.D., to its board of directors, effective immediately. “We are thrilled to welcome Brent and Tom to our board,” said Marc Stapley, Veracyte’s chief executive officer. “They are both seasoned business leaders with extensive healthcare industry […]
Prothena appoints Daniel G. Welch as Director and Chair Designate
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]
Karuna Therapeutics onboards William P. Kane as CCO
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, recently announces the appointment of Will Kane as chief commercial officer (CCO), effective February 6, 2023. “The addition of Will to our executive team represents an important step as we execute on […]